Comparative efficacy of long‐term antibiotic treatments in the primary prophylaxis of spontaneous bacterial peritonitis
- 28 March 2019
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 39 (8) , 1448-1458
Abstract
Background & Aims: Several antibiotic treatments aiming to prevent spontaneous bacterial peritonitis (SBP) in cirrhotic patients with low‐protein content in ascitic fluid have been tested; however, there are limited data on the comparative efficacy of these regimens. We assessed their comparative efficacy through a network meta‐analysis and using GRADE criteria to appraise quality of evidence.Methods: Through literature review through October 2018, we identified 10 randomized controlled trials comparing antibiotic treatments (norfloxacin, ciprofloxacin, trimethoprim/sulfamethoxazole and rifaximin) with each other or placebo. Primary outcome was SBP occurrence, with mortality rate and rate of other infections as secondary outcomes.Results: In comparison with placebo, moderate quality evidence supports the use of norfloxacin and ciprofloxacin in primary prophylaxis of SBP (risk ratio 0.23; 95% CI, 0.09‐0.56; P = 0.001 and 0.23; 0.07‐0.79; P = 0.02 respectively) while only low quality evidence suggests superiority of rifaximin (risk ratio 0.15; 0.05‐0.42). When antimicrobial agents were compared to each other, no significant difference was found. With regard to mortality, moderate quality supports the superiority of norfloxacin over placebo (risk ratio, 0.68; 95% CI, 0.47‐0.99; P = 0.04), while ciprofloxacin and rifaximin showed only a non‐significant benefit and no significant difference was found in the other comparisons. None of the tested antibiotics proved to significantly decrease the rate of other infections.Conclusions: Norfloxacin appears to have significant benefit both in terms of SBP prevention and mortality; ciprofloxacin represents a valuable option although without a clear survival benefit. Rifaximin shows interesting results but needs to be tested in further trials.Keywords
This publication has 29 references indexed in Scilit:
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Management of adult patients with ascites due to cirrhosisHepatology, 2009
- Role of Fluoroquinolones in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis: Meta-AnalysisClinical Gastroenterology and Hepatology, 2009
- Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in CirrhosisGastroenterology, 2007
- Sepsis in cirrhosis: report on the 7th meeting of the International Ascites ClubGut, 2005
- Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascitesJournal of Gastroenterology and Hepatology, 2005
- Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxisHepatology, 2002
- Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trialJournal of Hepatology, 1998
- Continuous Versus Inpatient Prophylaxis of the First Episode of Spontaneous Bacterial Peritonitis With NorfloxacinHepatology, 1997
- A prospective study of bacterial infections in patients with cirrhosisJournal of Hepatology, 1993